Skip to content

Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents

Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05874479
Acronym
AirPressureNYC
Enrollment
440
Registered
2023-05-25
Start date
2023-12-20
Completion date
2028-03-01
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Keywords

self-measured morning home systolic blood pressure (AM H-SBP)

Brief summary

Fine particulate matter \<2.5 µm (PM2.5) air pollution is the fifth leading risk factor for global mortality, with the largest portion of deaths due to cardiovascular disease (CVD). While several mechanisms are responsible, PM2.5-induced elevations in blood pressure (BP) may be relevant. Indoor portable air cleaners (PACs) are a novel approach to reduce exposure to PM2.5 and potentially lower blood pressure. The current study is being conducted to provide evidence that PACs reduce PM2.5 exposure and lower systolic blood pressure (SBP) in key patient populations.

Interventions

DEVICEActive PAC

The active PAC will contain HEPA filters inside the device.

DEVICESham PAC

The sham PAC will contain no HEPA filters inside the device.

Sponsors

NYU Langone Health
Lead SponsorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* self-reported nonsmokers living in a nonsmoking household. * adults living with hypertension (HTN) from NYC public housing.

Exclusion criteria

* History of major known arrhythmias (e.g. atrial flutter or fibrillation, ventricular tachycardia). * Screening systolic BP ≥160 mm Hg or diastolic BP ≥100 mm Hg (i.e. severe hypertension by the 2017 ACC/AHA BP guideline). * A change in drug regimen in the prior 2 weeks or a planned change in drug regimen during the first 30 days for those taking antihypertensive medication. * Current smoking or living with an active smoker who smokes indoors * Planned travel out of NYC for ≥2 weeks in next 6 months * Incarcerated * Pregnant * Unable/unwilling to consent * Established cardiovascular disease * End-stage renal disease (chronic kidney disease stage IV or on dialysis) * Barrier to technology use (e.g., visual or hearing impairment) * Lung disease requiring oxygen * Cancer receiving treatment

Design outcomes

Primary

MeasureTime frameDescription
Average Self-Measured Morning Home Systolic Blood Pressure (AM H-SBP) over 30 DaysUp to Day 30Participants measure HBP every day between 6-9 am.

Secondary

MeasureTime frameDescription
Average Self-Measured Morning Home Systolic Blood Pressure (AM H-SBP) over 90 DaysUp to Day 90Participants measure HBP every day between 6-9 am.
Average Self-Measured Morning Home Systolic Blood Pressure (AM H-SBP) over 180 DaysUp to Day 180Participants measure HBP every day between 6-9 am.

Countries

United States

Contacts

CONTACTJonathan Newman
AirPressureNYC@nyulangone.org(212) 263-9393
CONTACTElle Anastasiou Pesante
elle.anastasiou@nyulangone.org(646) 501-3613
PRINCIPAL_INVESTIGATORJonathan Newman

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026